Literature DB >> 23061324

Predictors of stigmatization towards use of various illicit drugs among emerging adults.

Joseph J Palamar1, Mathew V Kiang, Perry N Halkitis.   

Abstract

The stigma associated with illegal drug use is nearly universal, but each drug is associated with its own specific level of stigma. This study examined level of stigmatization towards users of various illegal drugs and determined what variables explain such attitudes. A sample of emerging adults (age 18 to 25) was surveyed throughout New York City (N = 1021) and lifetime use, level of exposure to users, and level of stigmatization was assessed regarding use of marijuana, powder cocaine, Ecstasy, and nonmedical use of opioids and amphetamine. Bivariate and multivariate analyses were conducted to examine predictors of stigmatization towards each drug. Results suggest that non-illegal drug users reported high levels of stigmatization towards users of all drugs, but lifetime marijuana users reported significantly lower levels of stigmatization towards users of all harder drugs. This may suggest that once an individual enters the realm of illegal drug use, stigmatization towards use of harder drugs decreases, potentially leaving individuals at risk for use of more dangerous substances. Since stigma and social disapproval may be protective factors against illegal drug use, policy experts need to consider the potential flaws associated with classifying marijuana with harder, more dangerous drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23061324     DOI: 10.1080/02791072.2012.703510

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  15 in total

1.  Attitudes and Beliefs About New Psychoactive Substance Use Among Electronic Dance Music Party Attendees.

Authors:  Joseph J Palamar; Patricia Acosta; Charles M Cleland
Journal:  Subst Use Misuse       Date:  2017-08-04       Impact factor: 2.164

2.  Religiosity and exposure to users in explaining illicit drug use among emerging adults.

Authors:  Joseph J Palamar; Mathew V Kiang; Perry N Halkitis
Journal:  J Relig Health       Date:  2014-06

Review 3.  Alternative drugs of abuse.

Authors:  M E Sutter; J Chenoweth; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

4.  Self-Reported Ecstasy/MDMA/"Molly" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.

Authors:  Joseph J Palamar; Patricia Acosta; Danielle C Ompad; Charles M Cleland
Journal:  Subst Use Misuse       Date:  2016-09-23       Impact factor: 2.164

5.  Diffusion of Ecstasy in the Electronic Dance Music Scene.

Authors:  Joseph J Palamar
Journal:  Subst Use Misuse       Date:  2020-07-30       Impact factor: 2.164

6.  Reasons for recent marijuana use in relation to use of other illicit drugs among high school seniors in the United States.

Authors:  Joseph J Palamar; Marybec Griffin-Tomas; Dimitra Kamboukos
Journal:  Am J Drug Alcohol Abuse       Date:  2015-06-26       Impact factor: 3.829

7.  Perceived cannabis use norms and cannabis use among adolescents in the United States.

Authors:  Li-Tzy Wu; Marvin S Swartz; Kathleen T Brady; Rick H Hoyle
Journal:  J Psychiatr Res       Date:  2015-03-06       Impact factor: 4.791

8.  Trends in the disapproval and use of marijuana among adolescents and young adults in the United States: 2002-2013.

Authors:  Christopher P Salas-Wright; Michael G Vaughn; Jelena Todic; David Córdova; Brian E Perron
Journal:  Am J Drug Alcohol Abuse       Date:  2015       Impact factor: 3.829

9.  Predictors of disapproval toward "hard drug" use among high school seniors in the US.

Authors:  Joseph J Palamar
Journal:  Prev Sci       Date:  2014-10

10.  Adverse psychosocial outcomes associated with drug use among US high school seniors: a comparison of alcohol and marijuana.

Authors:  Joseph J Palamar; Michael Fenstermaker; Dimita Kamboukos; Danielle C Ompad; Charles M Cleland; Michael Weitzman
Journal:  Am J Drug Alcohol Abuse       Date:  2014-08-29       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.